Research + insights
Explore the following resources on medication-assisted treatment, including original research that Ophelia has published in leading scientific journals. We're always looking for better ways to care for patients, and we're committed to sharing this knowledge with the world.
We conducted a study and found that almost 3/4 of Ophelia patients who had in-network insurance stayed in treatment for more than six months. Read article here.
Read more
Remote urine drug testing can be successfully adapted to exclusively virtual telehealth settings. Ophelia provides real-time, face-to-face high-quality care adherent to in-person best practices.
Read more
Telehealth for OUD holds promise to rapidly scale high quality accessible care for individuals affected by the opioid crisis.
Read more
Ophelia's patient outcomes
85% of Ophelia patients attend follow-up visits in the early weeks of treatment, more than 5x the national average (HEDIS: Engagement of AOD Treatment).
79% of Ophelia patients are retained in treatment at 180 days, more than 2x the national average(HEDIS: Pharmacotherapy for Opioid Use Disorder)
Ophelia earns a Net Promoter Score (NPS) of 97 among patients, 3x the industry average.
